CONMED (CNMD) reported Q4 adjusted earnings late Wednesday of $1.43 per diluted share, up from $1.34 a year earlier.

Two analysts polled by FactSet expected $1.33.

Revenue in the three months ended Dec. 31 rose to $373.2 million from $345.9 million a year earlier.

Two analysts surveyed by FactSet expected $367.2 million.

The company expects full-year adjusted EPS of $4.30 to $4.45 on revenue of $1.345 billion to $1.375 billion.

Analysts expect EPS of $4.50 on revenue of $1.381 billion.